Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/6/2017
SIETES contiene 91846 citas

 
 
 1 a 20 de 3376 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf 2017;26:635-41. [Ref.ID 101626]
2. Cita con resumen
Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]
4. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
5. Cita con resumen
Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]
6. Cita con resumen
Mudd PA, Thottathil P, Giordano T, Wetmore RF, Elden L, Jawad AF, Ahumada L, Gálvez JA. Association between ibuprofen use and severity of surgically managed posttonsillectomy hemorrhage. JAMA Otolaryngol Head Neck Surg 2017:4 de mayo. [Ref.ID 101564]
7. Cita con resumen
9.Tiene citas relacionadas Cita con resumen
Grosser T. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2017;376:1389-90. [Ref.ID 101526]
10.Tiene citas relacionadas
Attal N, Barrot M. Is pregabalin ineffective in acute or chronic sciatica?. N Engl J Med 2017;376:1169-70. [Ref.ID 101504]
11. Cita con resumen
Prada-Ramallal G, Takkouche B, Figueiras A. Diverging conclusions from the same meta-analysis in drug safety: source of data (primary versus secondary) takes a toll. Drug Saf 2017;40:351-8. [Ref.ID 101501]
12. Cita con resumen
Anónimo. Litigation is new tactic in opioid crisis. DIA Daily 2017:1. [Ref.ID 101500]
13.Enlace a cita originalTiene citas relacionadas
Karaca-Mandic P, Meara E, Morden NE. The growing problem of co-treatment with opioids and benzodiazepines. BMJ 2017;356:j1224. [Ref.ID 101495]
14.Enlace a cita originalTiene citas relacionadas Cita con resumen
Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 2017;356:j760. [Ref.ID 101494]
15.Tiene citas relacionadas Cita con resumen
Mathieson S, Chiro M, Maher CG, LcLachlan AJ, Latimer J, Koes BW, Hancock MJ, Harris I, Day RO, Billot L, Pik J, Jan S, Lin C-WC. Trial of pregabalin for acute and chronic sciatica. N Engl J Med 2017;376:1111-20. [Ref.ID 101483]
17. Cita con resumen
Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet 2017;389:736-47. [Ref.ID 101426]
18. Cita con resumen
Machado GC, Maher CG, Herreira PH, Day RO, Pinheiro MB, Ferreira ML. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis 2017:2 de febrero. [Ref.ID 101391]
19.
Felson DT. Safety of nonsteroidal antiinflammatory drugs.. N Engl J Med 2016;373:2595-6. [Ref.ID 101348]
20. Cita con resumen
Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola ME. Toxina botulínica en la neuralgia del trigémino. Med Clin (Barc) 2017;148:28-32. [Ref.ID 101340]
Seleccionar todas
 
 1 a 20 de 3376 siguiente >>